Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Physician Labeling Rule Review Extended

This article was originally published in The Pink Sheet Daily

Executive Summary

Office of Management & Budget adds 30 days to standard 90-day review. The rule, first submitted to OMB in January, now may not be released until August 6.

You may also be interested in...



Rx Labeling Final Rule Largely In Line With Draft Version

New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.

Rx Labeling Final Rule Largely In Line With Draft Version

New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.

Physician Labeling Final Rule Targeted For Release In May

FDA expects to release the physician labeling final rule by the end of May, according to HHS' semi-annual "unified agenda" published in the May 16 Federal Register

Related Content

Topics

UsernamePublicRestriction

Register

PS062691

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel